The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Biomimetic proteolipid vesicles for targeting inflamed tissues
Open accessAbstract
A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate the transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles - which we refer to as leukosomes - retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Lodish, H. F. (1986) · Cited by 5,650
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Self-citation(1987) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(87)90455-5 · Cited by 1,122
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A. D., Price, B. K., Cheng, M. M.-C., Decuzzi, P., Tour, J. M., Robertson, F., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.34 · Cited by 668
Self-citationAsymmetrical Lipid Bilayer Structure for Biological Membranes
BRETSCHER, M. S. (1972) · Nature New Biology · doi:10.1038/newbio236011a0 · Cited by 652
Cell membrane-camouflaged nanoparticles for drug delivery
Luk, B. T., & Zhang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.019 · Cited by 610
Zarbock, A., Ley, K., McEver, R. P., & Hidalgo, A. (2011) · Blood · doi:10.1182/blood-2011-07-343566 · Cited by 481
Chiappini, C., De Rosa, E., Martinez, J. O., Liu, X., Steele, J., Stevens, M. M., & Tasciotti, E. (2015) · Nature Materials · doi:10.1038/nmat4249 · Cited by 446
Self-citationDurr, E., Yu, J., Krasinska, K. M., Carver, L. A., Yates, J. R., Testa, J. E., Oh, P., & Schnitzer, J. E. (2004) · Nature Biotechnology · doi:10.1038/nbt993 · Cited by 420
Anselmo, A. C., Modery-Pawlowski, C. L., Menegatti, S., Kumar, S., Vogus, D. R., Tian, L. L., Chen, M., Squires, T. M., Sen Gupta, A., & Mitragotri, S. (2014) · ACS Nano · doi:10.1021/nn503732m · Cited by 350
Bioluminescence imaging of myeloperoxidase activity in vivo
Gross, S., Gammon, S. T., Moss, B. L., Rauch, D., Harding, J., Heinecke, J. W., Ratner, L., & Piwnica-Worms, D. (2009) · Nature Medicine · doi:10.1038/nm.1886 · Cited by 343
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
Azzopardi, E. A., Ferguson, E. L., & Thomas, D. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks379 · Cited by 312
Hu, C.-M. J., Fang, R. H., Luk, B. T., Chen, K. N. H., Carpenter, C., Gao, W., Zhang, K., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr00015j · Cited by 308
Clearance of pathological antibodies using biomimetic nanoparticles
Copp, J. A., Fang, R. H., Luk, B. T., Hu, C.-M. J., Gao, W., Zhang, K., & Zhang, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412420111 · Cited by 296
Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future
Allen, T. M. (1998) · Drugs · doi:10.2165/00003495-199856050-00001 · Cited by 283
Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform
Toledano Furman, N. E., Lupu-Haber, Y., Bronshtein, T., Kaneti, L., Letko, N., Weinstein, E., Baruch, L., & Machluf, M. (2013) · Nano Letters · doi:10.1021/nl401376w · Cited by 273
Self-citationDrug, enzyme and peptide delivery using erythrocytes as carriers
Millán, C. G., Marinero, M. L. S., Castañeda, A. Z., & Lanao, J. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.018 · Cited by 188
Parodi, A., Haddix, S. G., Taghipour, N., Scaria, S., Taraballi, F., Cevenini, A., Yazdi, I. K., Corbo, C., Palomba, R., Khaled, S. Z., et al. (2014) · ACS Nano · doi:10.1021/nn502807n · Cited by 181
Self-citationGlucocorticoids and Inflammation Revisited: The State of the Art
Franchimont, D. P., Kino, T., Galon, J., Meduri, G. U., & Chrousos, G. P. (2002) · NeuroImmunoModulation · doi:10.1159/000069969 · Cited by 158
Manconi, M., Caddeo, C., Sinico, C., Valenti, D., Mostallino, M. C., Biggio, G., & Fadda, A. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.010 · Cited by 149
Sigal, A., Bleijs, D. A., Grabovsky, V., van Vliet, S. J., Dwir, O., Figdor, C. G., van Kooyk, Y., & Alon, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.442 · Cited by 125
Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood
Doshi, N., Orje, J. N., Molins, B., Smith, J. W., Mitragotri, S., & Ruggeri, Z. M. (2012) · Advanced Materials · doi:10.1002/adma.201200607 · Cited by 113
Lund, R. R., Leth‐Larsen, R., Jensen, O. N., & Ditzel, H. J. (2009) · Journal of Proteome Research · doi:10.1021/pr801091k · Cited by 101
Sherman, M. B., Guenther, R. H., Tama, F., Sit, T. L., Brooks, C. L., Mikhailov, A. M., Orlova, E. V., Baker, T. S., & Lommel, S. A. (2006) · Journal of Virology · doi:10.1128/jvi.01137-06 · Cited by 97
Self-citationArroyo, A. G., Campanero, M. R., Sánchez‐Mateos, P., Zapata, J. M., Ursa, M. A., del Pozo, M. Á., & Sánchez‐Madrid, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.5.1277 · Cited by 94
Tunable Leuko-polymersomes That Adhere Specifically to Inflammatory Markers
Robbins, G. P., Saunders, R. L., Haun, J. B., Rawson, J., Therien, M. J., & Hammer, D. A. (2010) · Langmuir · doi:10.1021/la1017032 · Cited by 88
Hammer, D. A., Robbins, G. P., Haun, J. B., Lin, J. J., Qi, W., Smith, L. A., Ghoroghchian, P. P., Therien, M. J., & Bates, F. S. (2008) · Faraday Discussions · doi:10.1039/b717821b · Cited by 88
Kudgus, R. A., Walden, C. A., McGovern, R. M., Reid, J. M., Robertson, J. D., & Mukherjee, P. (2014) · Scientific Reports · doi:10.1038/srep05669 · Cited by 55
Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation
Chen, X., Wong, R., Khalidov, I., Wang, A. Y., Leelawattanachai, J., Wang, Y., & Jin, M. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.030 · Cited by 53
Nuclear Functions for Plasma Membrane‐Associated Proteins?
Benmerah, A., Scott, M. G. H., Poupon, V., & Marullo, S. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00102.x · Cited by 46
Mereghetti, P., Corsetto, P. A., Cremona, A., Rizzo, A. M., Doglia, S. M., & Ami, D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.07.003 · Cited by 40
Proteomic Profiling of a Biomimetic Drug Delivery Platform
Corbo, C., Parodi, A., Evangelopoulos, M., Engler, D. A., Matsunami, R. K., Engler, A. C., Molinaro, R., Scaria, S., Salvatore, F., & Tasciotti, E. (2014) · Current Drug Targets · doi:10.2174/1389450115666141109211413 · Cited by 39
Self-citationMembrane proteomic analysis of pancreatic cancer cells
Liu, X., Zhang, M., Go, V. L. W. B., & Hu, S. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-74 · Cited by 37
Lu (1999) · doi:10.1002/(sici)1097-4636(199908)46:2
Cited by
Exosome Theranostics: Biology and Translational Medicine
He, C., Zheng, S., Luo, Y., & Wang, B. (2018) · Theranostics · doi:10.7150/thno.21945 · Cited by 1,249
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Yue, W., Chen, L., Yu, L., Zhou, B., Yin, H., Ren, W., Liu, C., Guo, L., Zhang, Y., Sun, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09760-3 · Cited by 590
Metadata
- Authors
- Molinaro, R., Corbo, C., Martinez, J. O., Taraballi, F., Evangelopoulos, M., Minardi, S., Yazdi, I. K., Zhao, P., De Rosa, E., Sherman, M. B., De Vita, A., Toledano Furman, N. E., Wang, X., Parodi, A., & Tasciotti, E.
- Venue
- Nature Materials
- Published
- 2016-05-23
- Volume
- 15
- Issue
- 9
- Pages
- 1037-1046
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W2406375428
- Cited by
- 451
- References
- 42
- FWCI
- 14.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.